Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
P3 Health PartnersPIII +8.94%44 EV-to-EBIT is -1.54 as of Jul. 28, 2026. GuruFocus rates PIII with a GF Score™ of 44/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 471 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 212314.01% on this metric.
P3 Health Partners (NAS:PIII) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
P3 Health Partners's Enterprise Value for the quarter that ended in Mar. 2026 was $319 Mil.
P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-223 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners EV-to-EBIT Related Terms
P3 Health Partners EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, P3 Health Partners's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's EV-to-EBIT falls into.
P3 Health Partners's current Enterprise Value is $344 Mil.
P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-223 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (PIII) has a EV-to-EBIT of -1.54 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is P3 Health Partners' EV-to-EBIT too high?
P3 Health Partners' current EV-to-EBIT is -1.54. Based on the distribution chart, P3 Health Partners ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' EV-to-EBIT compare to CCEL and EHSI?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #999999 out of 471 companies for EV-to-EBIT. This places P3 Health Partners in the lower half of its industry. The industry median EV-to-EBIT is 15.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current EV-to-EBIT is -1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.51 — trading 20.1% above its estimated fair value. The current EV-to-EBIT is -1.54. P3 Health Partners' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For P3 Health Partners (PIII), the current EV-to-EBIT is -1.54 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.51 is trading 20.1% above its estimated GF Value™ of $8.75.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
EV-to-EBIT: -1.54
GF Value™: $8.75 vs. price of $10.51 (20.1% above fair value)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
44GF Score
Get the complete analysis for PIII
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 
